Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020–2022

Studying the prevalence of SARS-CoV-2 specific antibodies (seroprevalence) allows for assessing the impact of epidemic containment measures and vaccinations and estimating the number of infections regardless of viral testing. We assessed antibody-mediated immunity to SARS-CoV-2 induced by infections...

Full description

Saved in:
Bibliographic Details
Main Authors: Anna Solastie, Tuomo Nieminen, Nina Ekström, Hanna Nohynek, Lasse Lehtonen, Arto A. Palmu, Merit Melin
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Emerging Microbes and Infections
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2023.2222849
Tags: Add Tag
No Tags, Be the first to tag this record!